Basel-based Novartis Venture Fund and Versant Ventures have co-led a CHF 33m series-A financing round for biotech company Anokion.
Target Global I closed on €300m in 2015 and is now fully deployed
Existing investor Redalpine also participates in the round for the online ticketing platform
Deal is Sortera's 13th acquisition since it was established in 2006
Alpina began its ERP software buy-and-build platform with the acquisition of Oxaion in 2015